Physician profile
Thomas W Schultz
NPI 1023274776
$9,901.37
in general payments reported to CMS, 2019-2025
28 companies · $1,666 in 2025
The $1,666 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $190 · 2021: $1,790 · 2022: $1,397 · 2023: $1,254 · 2024: $2,734 · 2025: $1,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,696 · Travel and Lodging: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,696.07 |
| Travel and Lodging | $956.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,113.75 | 2021-2025 | Avvigo Guidance System, Watchman Access System, General - Balloon Catheters |
| Cvrx, INC. | $2,009.54 | 2019-2025 | Barostim Neo System |
| Medtronic, INC. | $1,263.08 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Linq II |
| Abbott Laboratories | $999.98 | 2019-2024 | Supera, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $903.75 | 2021-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $472.41 | 2020-2025 | Lifevest |
| Medtronic Vascular, INC. | $332.32 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $325.54 | 2020-2025 | |
| Biotronik INC. | $267.64 | 2019-2025 | |
| Inari Medical, INC. | $174.09 | 2021 | |
| Amgen INC. | $150.12 | 2021-2024 | Repatha |
| Cardiva Medical, INC. | $132.98 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $107.09 | 2020-2024 | Farxiga |
| Arbor Pharmaceuticals, INC. | $94.99 | 2020-2021 | |
| Shockwave Medical, INC | $93.91 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $69.29 | 2022-2023 | |
| Esperion Therapeutics, INC. | $62.62 | 2021 | |
| Philips North America LLC | $57.46 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $51.56 | 2022-2023 | Eliquis |
| Janssen Pharmaceuticals, INC | $45.87 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $33.63 | 2022-2025 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $31.58 | 2021 | |
| Nuwellis, INC. | $20.70 | 2025 | Aquadex Smartflow Console |
| Kiniksa Pharmaceuticals International, Plc | $18.99 | 2024 | Arcalyst |
| Livanova USA, INC. | $18.94 | 2022 | |
| Mallinckrodt Hospital Products INC. | $17.83 | 2022 | |
| Teleflex LLC | $16.93 | 2024 | Guideliner |
| Kiniksa Pharmaceuticals, Ltd. | $14.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.